Hyaluronidase (human Recombinant)

Hyaluronidase (human Recombinant) is an active ingredient in 18 FDA-listed drug products sold under 11 names.

Drugs containing Hyaluronidase (human Recombinant)

Products and strengths

NDCProductStrengthLabeler
57894-503Darzalex Faspro
Injection		30000 U/15mLJanssen Biotech, Inc.
50242-077Herceptin Hylecta
Injection, Solution		10000 U/5mLGenentech, Inc.
51662-1555Hyaluronidase
Injection, Solution		150 [USP'U]/mLHF Acquisition Co LLC, DBA HealthFirst
18657-117HYLENEX Recombinant
Injection, Solution		150 [USP'U]/mLAntares Pharma, Inc.
50242-554Ocrevus Zunovo
Injection, Solution		23000 U/23mLGenentech, Inc.
0003-3120Opdivo Qvantig
Injection, Solution		2000 U/mLE.R. Squibb & Sons, L.L.C.
0003-6120Opdivo Qvantig
Injection, Solution		2000 U/mLE.R. Squibb & Sons, L.L.C.
50242-260Phesgo
Injection, Solution		20000 U/10mLGenentech, Inc.
50242-245Phesgo
Injection, Solution		30000 U/15mLGenentech, Inc.
50242-108Rituxan Hycela
Injection, Solution		2000 U/mLGenentech, Inc.
50242-109Rituxan Hycela
Injection, Solution		2000 U/mLGenentech, Inc.
57894-522Rybrevant Faspro
Injection		44000 mg/22mLJanssen Biotech, Inc.
57894-515Rybrevant Faspro
Injection		30000 mg/15mLJanssen Biotech, Inc.
57894-514Rybrevant Faspro
Injection		28000 mg/14mLJanssen Biotech, Inc.
57894-510Rybrevant Faspro
Injection		20000 mg/10mLJanssen Biotech, Inc.
50242-933Tecentriq Hybreza
Injection		30000 U/15mLGenentech, Inc.
73475-3102VYVGART Hytrulo
Injection, Solution		2000 U/mLargenx US
73475-1221VYVGART Hytrulo
Injection, Solution		2000 U/mLargenx US